The Pan American Health Organization (PAHO) warns that antibiotic resistance has increased over the past decade in the Americas, including the Caribbean, particularly for carbapenems used as a last-line treatment for serious bacterial infections. PAHO says the trend is concerning because it reduces treatment options and makes patient care for severe infections more difficult.

PAHO’s data, drawn from the Latin American and Caribbean Antimicrobial Resistance Surveillance Network (ReLAVRA+), focus on resistance patterns in key bacteria. In Klebsiella pneumoniae, resistance to carbapenems rises from about 15% in 2015 to 26% in 2024, based on estimates from 15 countries. For Escherichia coli, resistance increases from roughly 3% to 5%, based on data from 13 countries. PAHO also reports very high median resistance to carbapenems in Acinetobacter baumannii, reaching 77% in 2024 across seven countries reporting that combination.

Outlets emphasize PAHO’s call for action, including strengthening surveillance, preventing infections, and improving access to new antibiotics while ensuring appropriate use. One report highlights the broader regional framing, while another adds specific bacterial findings and PAHO leadership commentary.